S. No Age (Year) Gender Histology Stage Treatment Method RT dose (cGy) Chemotherapy Status at last visit
1 42 M Follicular lymphoma IA RT 2975 None NED
2 65 M Diffuse large B cell lymphoma IAE IFRT + Chemo 3600 R-CHOP NED
3 56 M Diffuse large B cell lymphoma IAE IFRT + Chemo 3600 R-CHOP Failure at testes and stomach
4 66 M MALT IAE IFRT 3600 None NED
5 91 F Diffuse large B cell lymphoma IE IFRT + Chemo 3600 R-CDOP Failure at left inguinal LN and right breast
6 61 F Diffuse large B cell lymphoma IIBE IFRT + Chemo 3600 R-CHOP NED
7 50 F Nodular sclerosis; HD IIAE IFRT + Chemo 2000 ABVD NED
8 68 M Diffuse large B-cell lymphoma IAE IFRT + Chemo 3600 R-CHOP NED
9 59 F Large cell lymphoma;burkitts IV IFRT + Chemo 3600 R-CHOP NED
10 95 M Low grade lymphoma; atypical lymphoma cells IAE IFRT + Chemo 4500 Rituxan NED
11 56 F MALT IV Chemo only  Not treated Rituxan NED
12 49 M NK-T cell lymphoma IAE IFRT + Chemo 6000 CHOP Failure in liver
13 55 F MALT IAE IFRT 3000 None NED
14 72 F Large B-cell lymphoma IIAE IFRT 4000 None NED
RT: radiation therapy;cGy:centigray; NED: no evidence of disease; M: male; F: female; LN: lymph node; chemo: chemotherapy;HD: Hodgkin’s disease; E:extranodal
Table 3: Individual Patient Characteristics (N=14).